US › Healthcare

Nutriband Inc (NTRB)

US · Healthcare · Biotechnology

$2.85+1.42%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$433,399
Revenue YoY
-35.1%
Net profit
$-1.2M
Profit YoY
+10.6%
EPS
$-0.08
EPS estimate
$-1.89
Net margin
-286.6%

EPS came in at -0.08 against a street estimate of -1.89 — a beat of 95.8%.

Key statistics

Market cap
$34.6M
Forward P/E
370.4
P/B
5.79
Book value
$0.49
EPS (TTM)
$-2.56
52-week high
$8.63
52-week low
$2.81
50-day MA
$3.21
200-day MA
$4.30
Beta
1.94

Analyst view

Analysts rate Nutriband Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $15.00.

Shareholding

Insiders
56.81%
Institutions
3.08%

Largest institutional holders

FundStake
Vanguard Capital Management, LLC1.44%
Geode Capital Management, LLC0.58%
UBS Group AG0.27%
Vanguard Fiduciary Trust Co0.21%
State Street Corp0.21%
Northern Trust Corp0.11%
Haven Private, LLC0.09%
BlackRock Inc0.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Nutriband Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.